Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Plos One|September 23, 2020
Adding the temporal domain to PET radiomic featuresWyanne A Noortman, Dennis Vriens, Cornelis H Slump, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
EGFR overexpressing cells and tumors are dependent on autophagy for growth and survivalBarry Jutten, Tom G Keulers, Marco B E Schaaf, et al.
Scientific Reports|December 13, 2019
CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer modelsFokko J Huizing, Javad Garousi, Jasper Lok, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2026
Mitochondria-targeted OXPHOS inhibition enhances radiotherapy efficacy by disrupting mitochondrial functionAnne P M Beerkens, Paolo S Taracatac, Wenny J M Peeters, et al.
Endocrine-Related Cancer|January 18, 2014
LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagyAnika Nagelkerke, Anieta M Sieuwerts, Johan Bussink, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancerOlga C J Schuurbiers, Johannes H A M Kaanders, Henricus F M van der Heijden, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancerTineke W H Meijer, Wenny J M Peeters, Ludwig J Dubois, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2015
Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapyRobin Wijsman, Frank Dankers, Esther G C Troost, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 5, 2016
Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMATRobin Wijsman, Frank Dankers, Esther G C Troost, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2017
Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT imagesJanna E van Timmeren, Ralph T H Leijenaar, Wouter van Elmpt, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Plos One|September 23, 2020
Adding the temporal domain to PET radiomic featuresWyanne A Noortman, Dennis Vriens, Cornelis H Slump, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
EGFR overexpressing cells and tumors are dependent on autophagy for growth and survivalBarry Jutten, Tom G Keulers, Marco B E Schaaf, et al.
Scientific Reports|December 13, 2019
CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer modelsFokko J Huizing, Javad Garousi, Jasper Lok, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2026
Mitochondria-targeted OXPHOS inhibition enhances radiotherapy efficacy by disrupting mitochondrial functionAnne P M Beerkens, Paolo S Taracatac, Wenny J M Peeters, et al.
Endocrine-Related Cancer|January 18, 2014
LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagyAnika Nagelkerke, Anieta M Sieuwerts, Johan Bussink, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancerOlga C J Schuurbiers, Johannes H A M Kaanders, Henricus F M van der Heijden, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancerTineke W H Meijer, Wenny J M Peeters, Ludwig J Dubois, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2015
Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapyRobin Wijsman, Frank Dankers, Esther G C Troost, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 5, 2016
Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMATRobin Wijsman, Frank Dankers, Esther G C Troost, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2017
Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT imagesJanna E van Timmeren, Ralph T H Leijenaar, Wouter van Elmpt, et al.
Pageof 22